EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome

Seok-Jin Lee iD, Jee Yeon Baek iD, Ji Young Lee iD, Ji-Man Kang iD, Jong Gyun Ahn iD

Yonsei Medical Journal · 2024

DOI: 10.3349/ymj.2023.0366 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Yonsei Medical Journal, 2024. Verfasst von Seok-Jin Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Fever, Hereditary Autoinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor receptor-associated periodic syndrome (TRAPS, OMIM: #142680) is a rare autoinflammatory disease (AID) with recurrent febrile episodes. To our knowledge, we report herein the first case of a patient with TRAPS in South Korea whose symptoms included fever, arthralgia, abdominal pain, rash, myalgia, cough, and lymphadenopathy. A pathogenic de novo mutation, c.175T>C (p.Cys59Arg), in the tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) gene, was confirmed by gene sequencing. The patient has been with tocilizumab (an interleukin-6 inhibitor); tocilizumab administration every other week has completely alleviated the patient's symptoms. Our report further expands the clinical spectrum of patients with TRAPS and reaffirms the use of tocilizumab as a viable alternative treatment option for those patients who are unsatisfactorily responsive to other commonly used biologics, such as canakinumab, anakinra, infliximab, and etanercept. Furthermore, our report may aid in increasing awareness about the existence of mutation-confirmed TRAPS in South Korea in addition to emphasizing the importance of actively pursuing genetic testing to correctly diagnose rare AID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FeverHereditary Autoinflammatory DiseasesHumansReceptors, Tumor Necrosis Factor, Type IMutationEtanercept

Stichwörter der Autor:innen

TNFRSF1ATRAPSautoinflammatory diseasetocilizumabtumor necrosis factor receptor-associated periodic syndrome

Substanzen

Receptors, Tumor Necrosis Factor, Type IEtanercept

Autor:innen und Institutionen

  • Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea.
  • Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea. jgahn@yuhs.ac.

ORCID-Profile: Seok-Jin Lee, Jee Yeon Baek, Ji Young Lee, Ji-Man Kang, Jong Gyun Ahn

Zitieren

APA

Lee, S. J., Baek, J. Y., Lee, J. Y., Kang, J. M., & Ahn, J. G. (2024). The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2023.0366

Vancouver

Lee SJ, Baek JY, Lee JY, Kang JM, Ahn JG. The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome. Yonsei Medical Journal. 2024. doi:10.3349/ymj.2023.0366

BibTeX
@article{Lee2024,
  author = {Lee, Seok-Jin and Baek, Jee Yeon and Lee, Ji Young and Kang, Ji-Man and Ahn, Jong Gyun},
  title = {The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome},
  journal = {Yonsei Medical Journal},
  year = {2024},
  doi = {10.3349/ymj.2023.0366}
}
Kostenlos starten →